This independent TM-1002 assay confirms Semaglutide 20mg from Orbitrex Peptides at 99.855% purity. The analysis was conducted by Trust Pointe Analytics on October 10, 2025.
Semaglutide is a GLP-1 receptor agonist researched for its potential effects on metabolic regulation, weight management, and glycemic control. A purity level of 99.855% indicates minimal contamination and high-grade synthesis.
The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.